Navigation Links
Anadys Pharmaceuticals Reports First Quarter 2009 Financial Results and Highlights
Date:4/23/2009

lopment programs, including a review of the ANA598 antiviral data that was presented at EASL. A live webcast of the call will be available online at www.anadyspharma.com. A telephone replay will also be available approximately one hour after completion of the call. To access the telephone replay, dial 888-286-8010 (domestic) or 617-801-6888 (international), passcode 85383527. The webcast and telephone replay will be available through May 7, 2009.

About Anadys

Anadys Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to improving patient care by developing novel medicines in the areas of hepatitis C and oncology. For the treatment of chronic hepatitis C, the Company is developing two potentially complementary agents, ANA598, a non-nucleoside polymerase inhibitor and ANA773, an oral inducer of endogenous interferons that acts via the TLR7 pathway. The Company is also developing ANA773 for the treatment of cancer.

Safe Harbor Statement

Statements in this press release that are not strictly historical in nature constitute "forward-looking statements." Such statements include, but are not limited to, references to (i) the potency, safety and tolerability profile of ANA598, which may not be duplicated in future cohorts at higher doses or future clinical studies of longer duration; (ii) the potential for the first Phase II study of ANA598 to demonstrate the impact of ANA598 on durable clinical benefit (SVR) in HCV patients; (iii) the expectation that ANA598 will be active in long-term studies in combination with pegylated interferon and ribavirin and the ability to dose ANA598 for up to 48 weeks in future combination studies; (iv) the ability of Anadys to transition into Phase II studies of ANA598 during 2009; (v) the ability to proceed to the 2000 mg dose level in the ANA7
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
2. Anadys Pharmaceuticals to Report Third Quarter 2007 Financial Results
3. Anadys Pharmaceuticals to Present at the Acumen BioFin Rodman & Renshaw Healthcare Conference
4. Anadys Pharmaceuticals Reports Third Quarter 2007 Financial Results and Operational Highlights
5. Anadys Pharmaceuticals to Present at the Piper Jaffray Health Care Conference
6. Anadys Pharmaceuticals to Present at the JPMorgan Healthcare Conference
7. Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
8. Anadys Pharmaceuticals to Report Fourth Quarter and Year-End 2007 Financial Results
9. Anadys Pharmaceuticals to Present at the Susquehanna SIGnificant Options in Healthcare Conference
10. Anadys Pharmaceuticals Commences Phase I Clinical Trial of ANA773 in Cancer Patients
11. Anadys Pharmaceuticals to Present at the Cowen and Company Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... how facets form and develop on platinum nanocubes ... nanocrystal design and reveal that a nearly 150 ... at the nanoscale. , Researchers with the U.S. ... (Berkeley Lab) used highly sophisticated transmission electron microscopes ... the physical mechanisms that control the evolution ...
(Date:8/22/2014)... 2014 Research and Markets has ... Enzymes, Kits, & Reagents (Cloning, Epigenetics, PCR, Restriction Digestion, ... their offering. The global molecular biology ... and is expected to grow at a CAGR of ... enzymes, kits, & reagents find applications in a large ...
(Date:8/21/2014)... LYNBROOK, N.Y. , Aug. 21, 2014 /PRNewswire/ ... a biopharmaceutical company developing first in class collagenase-based ... histolyticum or CCH) in the U.S. and XIAPEX ... statistically significant results from a randomized, double-blind Phase ... of cellulite, or edematous fibrosclerotic panniculopathy. The results ...
(Date:8/21/2014)... Ireland , August 21, 2014 /PRNewswire/ ... Markets ( http://www.researchandmarkets.com/research/3zh3q8/global_hormone ) has announced the addition ... 2014-2018"  report to their offering.  ... known as hormone therapy, is a means ... being produced by the body. This type ...
Breaking Biology Technology:Shaping the future of nanocrystals 2Shaping the future of nanocrystals 3Shaping the future of nanocrystals 4Global Molecular Biology Enzymes, Kits, & Reagents (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing) Market - Forecast to 2018 2Global Molecular Biology Enzymes, Kits, & Reagents (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing) Market - Forecast to 2018 3BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 2BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 3BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 4BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 5Global Hormone Replacement Therapy Market 2014-2018: Key Vendors are Actavis, Bayer, Merck & Co, Novartis and Novo Nordisk 2
... March 10, 2011 Cell Therapeutics, Inc. ("CTI") (Nasdaq ... design of a randomized pivotal trial of pixantrone for ... discussions with the  U.S. Food and Drug Administration,s (the ... new clinical trial, referred to as the PIX-R or ...
... German . , From the wooden bars in a xylophone ... box of a guitar or violin, musical instruments are the most ... instruments create acoustic waves that we hear as sound. The purity ... the vibration amplitude, that is, the mechanical losses of the system. ...
... - Tomorrow,s nonvolatile memory devices computer memory that ... will profoundly change electronics, and Cornell University researchers have ... performance. Using a very fast oscilloscope, ... of Physics, and Robert Buhrman, the J.E. Sweet Professor ...
Cached Biology Technology:FDA Provides Guidance for Design of Cell Therapeutics' Pixantrone Pivotal Trial 2FDA Provides Guidance for Design of Cell Therapeutics' Pixantrone Pivotal Trial 3FDA Provides Guidance for Design of Cell Therapeutics' Pixantrone Pivotal Trial 4FDA Provides Guidance for Design of Cell Therapeutics' Pixantrone Pivotal Trial 5How long does a tuning fork ring? 2Physicists measure current-induced torque in nonvolatile magnetic memory devices 2
(Date:8/21/2014)... reduction in smog-producing toxins in past decade, GTA ... study shows that while the Greater Toronto Area ... that contribute to smog, the city continues to ... Smog, which can cause or aggravate health problems ... produced by a set of complex photochemical reactions ...
(Date:8/21/2014)... Bacteria growing in near darkness use a previously unknown ... a research team led by a Penn State University ... further research aimed at improving plant growth, harvesting energy ... now occurring on Lake Erie and other lakes worldwide. ... the Science Express edition of the journal ...
(Date:8/21/2014)... , Aug. 21, 2014 /PRNewswire-iReach/ -- LiveScan ... has agreed to a partnership with Gabriel Health ... fastest growing Certified Nursing Assistant preparatory ... Institute  an exclusive member of Binary,s LiveScan service ... Biometrics will improve its service capabilities by ...
Breaking Biology News(10 mins):Despite a significant reduction in smog-producing toxins, the Greater Toronto Area still violates Canada's standards for ozone air pollution 2Hot-spring bacteria reveal ability to use far-red light for photosynthesis 2Hot-spring bacteria reveal ability to use far-red light for photosynthesis 3LiveScan Provider Binary Biometrics Announces Partnership with Preeminent CNA School, Gabriel Health Institute to Expand Services in Orlando Region 2LiveScan Provider Binary Biometrics Announces Partnership with Preeminent CNA School, Gabriel Health Institute to Expand Services in Orlando Region 3
... Biophysical Society is pleased to announce that it will ... with the International Biophysics Congress in Long Beach, California, ... talks and poster sessions that take place during the ... to discuss current policy issues facing our nation. The ...
... New research at the University of Chicago finds evidence ... the pain of loneliness: They create people in their ... not a very efficient way to alleviate ones loneliness, ... to do so, said Nicholas Epley, Assistant Professor of ...
... This release is also available in French . ... to community involvement today with a $1-million donation to ... and Hospital (MNI), affiliated with McGill University and the ... $40-million initiative to invest in people and expand facilities ...
Cached Biology News:Biophysical Society to host discussions on the teaching of evolution and on the energy crisis 2People not always needed to alleviate loneliness 2People not always needed to alleviate loneliness 3Building the future -- 21st century nano tools to repair the nervous system 2
Request Info...
Epi-Grids™ Colony Grid Templates are easy-to-use griding templates that allow rapid organization of colonies from initial screening plates and for preparing precise master plates....
Detect and measure levels of mouse IgG3 antibody isotypes quickly and easily....
... Each vial contains 200 g of lyophilized ... sequence (C-terminal amino acids 380-402; GLTPSAWEASSLRSSRHSGLSHF. ... antigen for production of Cayman's EP1 receptor ... be used in conjunction with this antibody ...
Biology Products: